Can I Get GLP-1 From My Doctor? Understanding Prescription

Last reviewed: May 14, 2026

Last updated: May 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, your doctor can prescribe GLP-1 medications for weight loss if you meet specific clinical criteria. Current guidelines recommend GLP-1 therapy for adults with BMI of 30 or higher, or 27 or higher with weight-related comorbidities like hypertension or type 2 diabetes. However, prescription access involves a comprehensive medical evaluation beyond weight alone.

Before starting GLP-1 treatment, understanding what your doctor evaluates—and how individual metabolic factors may influence your response—empowers you to have a more targeted conversation about whether this treatment aligns with your health goals. PlexusDx focuses on precision wellness by helping patients and providers consider both clinical readiness and genetic predispositions in peptide pathways.

How Doctors Evaluate GLP-1 Eligibility

Physicians use standardized criteria to determine GLP-1 candidacy, including body mass index, cardiovascular risk factors, and metabolic history. A full medical evaluation includes blood pressure, glucose metabolism, kidney function, and family history of thyroid disease. This assessment ensures GLP-1 is safe and appropriate for your specific health profile.

Your doctor will also assess medication interactions, previous weight-loss attempts, and lifestyle readiness. Some providers use structured questionnaires to evaluate motivation and commitment to behavioral support. This thorough vetting reduces adverse events and improves treatment adherence over time.

Medical Requirements and Documentation Standards

Insurance coverage and prescription authorization typically require documented medical necessity. Providers must document baseline weight, BMI, comorbidities, and medical contraindications. Many insurers require a letter of medical necessity or prior authorization before approval. Compounded GLP-1 from licensed 503A pharmacies offers an alternative for patients seeking faster access or lower costs.

Assessment Factor	What Your Doctor Evaluates
BMI and Weight History	Current BMI ≥30 (or ≥27 with comorbidities); documented weight trends over 12+ months
Metabolic Status	Fasting glucose, HbA1c, lipid panel, kidney function (eGFR), liver function tests
Cardiovascular Risk	Blood pressure, personal or family history of heart disease, stroke, or atherosclerosis
Thyroid and GI History	Personal or family thyroid cancer history; prior pancreatitis or gastroparesis; medication list
Contraindications	Multiple endocrine neoplasia type 2 (MEN2), medullary thyroid carcinoma, severe renal impairment, active suicidal ideation
Lifestyle Readiness	Dietary compliance, exercise capacity, mental health stability, access to behavioral support

The Role of Genetic Predispositions in Prescription Planning

Recent evidence suggests individual variation in GLP-1 and GIPR receptor genetics influences how patients metabolize and respond to these medications. Variants in GLP1R rs6923761 and GIPR rs1800437 may provide context about baseline sensitivity to GLP-1 pathways. While genetics do not predict exact medication response, this information can inform personalized dosing and formulation selection discussions with your provider.

The Precision Peptide Genetic Test identifies predispositions in key peptide pathway genes, including GLP-1 receptor sensitivity and appetite-regulation variants like FTO and MC4R. These insights should be interpreted with a qualified healthcare provider as part of a comprehensive treatment plan, not as standalone predictors of outcome. When shared with your doctor, genetic context may support more targeted treatment conversations.

Safety Considerations and When to Seek Alternative Access Routes

Some patients experience delays obtaining prescriptions through insurance due to prior authorization requirements or supply constraints. For these individuals, compounded GLP-1 and tirzepatide from licensed 503A pharmacies offer medically supervised alternatives. Compounded options bypass some insurance delays while maintaining pharmacy quality standards and provider oversight.

Regardless of prescription source—branded, generic, or compounded—initiate treatment only with qualified medical supervision. Report any adverse effects, including nausea, constipation, or signs of pancreatitis, to your provider immediately. Regular follow-up appointments ensure dose adjustments and early identification of concerns.

How PlexusDx Supports a More Personalized Approach

PlexusDx genetic testing may help provide context about your individual metabolic predispositions in GLP-1 and appetite-regulation pathways. Variants in GLP1R, GIPR, FTO, and MC4R genes can inform personalized discussions with your provider about treatment selection and expected response patterns. This information should be interpreted with a qualified healthcare provider as part of your overall clinical assessment.

The Precision Peptide Genetic Test ($99 add-on or $298 standalone) reveals predispositions in peptide genetic pathways—not pharmacogenomic drug metabolism. Key variants like GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 may correlate with baseline GLP-1 sensitivity and appetite signaling. However, genetics alone do not predict exact medication response; clinical factors and individual variability remain central to treatment outcomes.

When discussing GLP-1 prescription options with your doctor, sharing genetic predisposition results can support a more informed, personalized conversation. Your provider can weigh these insights alongside your BMI, comorbidities, metabolic markers, and lifestyle factors. This precision-wellness approach may help identify whether a standard dose, microdose protocol, or dual-compound formulation aligns best with your physiology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the minimum BMI required for a doctor to prescribe GLP-1?

Current guidelines recommend GLP-1 for BMI ≥30, or BMI ≥27 with weight-related comorbidities such as type 2 diabetes, hypertension, or cardiovascular disease. Your doctor may prescribe below these thresholds if clinical circumstances warrant.

Can my doctor prescribe GLP-1 off-label for lower BMI?

Yes, doctors can prescribe off-label, but this requires documented medical justification and typically involves informed consent. Insurance coverage becomes less predictable. Compounded GLP-1 options may offer flexibility for off-label or lower-dose scenarios under medical supervision.

How long does medical evaluation for GLP-1 prescription take?

Initial evaluation typically requires one office visit for history, physical examination, and baseline labs (lipids, glucose, kidney function). Results may take 1–2 weeks. Some providers expedite authorization if urgent clinical need exists. Compounded pharmacies can sometimes initiate faster with provider authorization.

What if my insurance denies GLP-1 coverage?

Appeals processes vary by insurer but typically require additional documentation of medical necessity. PlexusDx compounded GLP-1 from licensed 503A pharmacies offers a direct-pay alternative at $149/mo for injections or $209+/month for oral formulations, bypassing insurance delays.

Can genetic testing help predict if GLP-1 will work for me?

The Precision Peptide Genetic Test identifies predispositions in GLP-1 and appetite-regulation pathways but does not predict exact medication response. Results provide context that may inform your provider's treatment selection and dosing strategy within a comprehensive clinical evaluation.

Can I Get GLP-1 From My Doctor? Understanding Prescription Options for Weight Loss